MOLECULAR TEMPLATES INC (MTEM) Forecast, Price Target & Analyst Ratings

NASDAQ:MTEM • US6085502085

Current stock price

0.1072 USD
-0.03 (-23.43%)
At close:
0.1113 USD
+0 (+3.82%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MOLECULAR TEMPLATES INC (MTEM).

Forecast Snapshot

Consensus Price Target

Price Target
$18.36
+ 17,026.87% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2024
EPS Estimate
-$1.05
Revenue Estimate
336.6K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$18.36
Upside
+ 17,026.87%
From current price of $0.11 to mean target of $18.36, Based on 7 analyst forecasts
Low
$18.18
Median
$18.36
High
$18.90

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for MTEM. The average price target is 18.36 USD. This implies a price increase of 17026.87% is expected in the next year compared to the current price of 0.1072.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MTEM Current Analyst RatingMTEM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

MTEM Historical Analyst RatingsMTEM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
MTEM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MTEM.
In the previous month the buy percentage consensus was at a similar level.
MTEM was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-11-11BarclaysMaintains Overweight
2022-05-27B of A SecuritiesDowngrade Buy -> Underperform
2021-04-21B of A SecuritiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2024
EPS Estimate
-$1.05
Revenue Estimate
336.6K
Revenue Q2Q
-95.05%
EPS Q2Q
-28.12%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
MTEM revenue by date.MTEM revenue by date.
38.7M
105.31%		19.75M
-48.97%		57.306M
190.16%		12.58M
-78.05%		1.282M
-89.81%		9.18M
616.07%		15.3M
66.67%		33.66M
120.00%		49.98M
48.48%		61.2M
22.45%
EBITDA
YoY % growth
MTEM ebitda by date.MTEM ebitda by date.
-73.44M
24.23%		-81.09M
-10.42%		-3.821M
95.29%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MTEM ebit by date.MTEM ebit by date.
-80.07M
20.60%		-88.47M
-10.49%		-10.466M
88.17%		-23.196M
-121.63%		-35.844M
-54.53%		-61.2M
-70.74%		-26.214M
57.17%		-10.2M
61.09%		4.998M
149.00%		14.076M
181.63%
Operating Margin
MTEM operating margin by date.MTEM operating margin by date.
-206.90%-447.95%-18.26%-184.39%-2,795.93%-666.67%-171.33%-30.30%10.00%23.00%
EPS
YoY % growth
MTEM eps by date.MTEM eps by date.
-1.51
29.11%		-24.77
-1,540.33%		-1.55
93.74%		-2.99
-92.81%		-2.40
19.80%		-2.78
-16.17%		-3.18
-14.29%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-1.05
-28.12%		-0.89
-21.56%
Revenue
Q2Q % growth		336.6K
-95.05%		351.9K
-94.98%
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-7.423M
-44.41%		-8.419M
-56.75%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MTEM Yearly Revenue VS EstimatesMTEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M
MTEM Yearly EPS VS EstimatesMTEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-21.57%
EPS Next 5 Year
-19.70%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-46.28%
Revenue Next 5 Year
-10.69%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MOLECULAR TEMPLATES INC / MTEM Forecast FAQ

What is the average price target for MOLECULAR TEMPLATES INC (MTEM) stock?

7 analysts have analysed MTEM and the average price target is 18.36 USD. This implies a price increase of 17026.87% is expected in the next year compared to the current price of 0.1072.

What are the consensus estimates for MOLECULAR TEMPLATES INC (MTEM) next earnings?

The consensus EPS estimate for the next earnings of MOLECULAR TEMPLATES INC (MTEM) is -1.05 USD and the consensus revenue estimate is 336.60K USD.

Can you provide the expected long term growth rate for MOLECULAR TEMPLATES INC stock?

The expected long term growth rate for MOLECULAR TEMPLATES INC (MTEM) is -46.28%.